Share This Page
Drug Price Trends for ME-NAPHOS-MB-HYO
✉ Email this page to a colleague

Average Pharmacy Cost for ME-NAPHOS-MB-HYO
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
ME-NAPHOS-MB-HYO 1 TABLET | 58657-0454-01 | 3.76326 | EACH | 2025-01-22 |
ME-NAPHOS-MB-HYO 1 TABLET | 58657-0454-01 | 3.75794 | EACH | 2024-12-18 |
ME-NAPHOS-MB-HYO 1 TABLET | 58657-0454-01 | 3.48860 | EACH | 2024-11-20 |
ME-NAPHOS-MB-HYO 1 TABLET | 58657-0454-01 | 3.71579 | EACH | 2024-10-23 |
ME-NAPHOS-MB-HYO 1 TABLET | 58657-0454-01 | 3.94574 | EACH | 2024-09-18 |
ME-NAPHOS-MB-HYO 1 TABLET | 58657-0454-01 | 4.18692 | EACH | 2024-08-21 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for ME-NAPHOS-MB-HYO 1 Tablets
Introduction
ME-NAPHOS-MB-HYO 1 Tablets are a multi-component medication designed to treat symptoms of irritative voiding, including those associated with lower urinary tract infections and diagnostic procedures. The drug combines methenamine, monobasic sodium phosphate, methylene blue, and hyoscyamine sulfate to provide antiseptic, antispasmodic, and urinary acidifying effects.
Market Demand
The demand for ME-NAPHOS-MB-HYO 1 Tablets is driven by the prevalence of urinary tract infections (UTIs) and other urinary tract disorders. UTIs are common, affecting millions of people worldwide each year, particularly women and the elderly. This consistent demand ensures a stable market for medications that alleviate UTI symptoms.
Competitive Landscape
The market for urinary tract infection treatments is competitive, with various medications and brands available. However, ME-NAPHOS-MB-HYO 1 Tablets have a unique combination of active ingredients that sets them apart from other treatments. This differentiation can be a significant advantage in attracting patients and healthcare providers looking for a comprehensive solution to UTI symptoms[1][3][4].
Pricing Strategy
The pricing of ME-NAPHOS-MB-HYO 1 Tablets varies significantly depending on the pharmacy and location. Here are some price points observed:
- Discounted Prices: As low as $23.32 at certain pharmacies with coupons.
- Average Prices: Ranges from $68.68 to $127.97 at various pharmacies.
- High-End Prices: Up to $173.57 at some retail pharmacies[4].
Price Projections
Given the stable demand and competitive landscape, here are some price projection considerations:
Short-Term Projections
In the short term, prices are likely to remain stable due to the consistent demand for UTI treatments. However, there could be minor fluctuations based on promotional offers, coupons, and pharmacy-specific discounts.
Long-Term Projections
Long-term price projections may be influenced by several factors:
- Generic Competition: If generic versions of the drug become available, prices could decrease due to increased competition.
- Regulatory Changes: Any changes in regulatory policies or FDA approvals could impact pricing.
- Market Dynamics: Shifts in market demand or the introduction of new treatments could also affect pricing.
Cost Factors
Several cost factors influence the pricing of ME-NAPHOS-MB-HYO 1 Tablets:
Manufacturing Costs
Method Pharmaceuticals, the manufacturer, focuses on cost-effective production. However, the cost of raw materials, such as methenamine, monobasic sodium phosphate, methylene blue, and hyoscyamine sulfate, can fluctuate and impact the final product price[5].
Distribution and Marketing
The costs associated with distribution, marketing, and sales also play a significant role in the final pricing of the drug.
Pharmacy Margins
Pharmacies add their margins to the wholesale price, which can vary widely depending on the pharmacy chain and location.
Consumer and Healthcare Provider Perspectives
From a consumer perspective, the affordability and effectiveness of ME-NAPHOS-MB-HYO 1 Tablets are crucial. Consumers often seek medications that offer comprehensive relief from UTI symptoms at a reasonable price. Healthcare providers also consider the efficacy and safety profile of the medication when prescribing it to patients.
Safety and Efficacy
The safety and efficacy of ME-NAPHOS-MB-HYO 1 Tablets are well-documented. The drug is indicated for the relief of local symptoms such as hypermotility and is effective in maintaining an acidic urine pH necessary for methenamine degradation. However, precautions such as potential interactions with other medications and use in pregnant or breastfeeding women must be considered[1][3].
Regulatory Status
ME-NAPHOS-MB-HYO 1 Tablets are classified as an unapproved drug by the FDA, which may impact their market positioning and pricing. Despite this, the drug remains widely used due to its established efficacy and safety profile[3].
Key Takeaways
- Stable Demand: The consistent demand for UTI treatments ensures a stable market for ME-NAPHOS-MB-HYO 1 Tablets.
- Competitive Pricing: Prices vary widely depending on the pharmacy and location, with discounts and coupons available.
- Long-Term Factors: Generic competition, regulatory changes, and market dynamics could influence long-term pricing.
- Cost Factors: Manufacturing, distribution, marketing, and pharmacy margins all impact the final price.
- Consumer and Healthcare Provider Perspectives: Affordability, efficacy, and safety are key considerations.
FAQs
Q: What are the active ingredients in ME-NAPHOS-MB-HYO 1 Tablets? A: The active ingredients are methenamine, monobasic sodium phosphate, methylene blue, and hyoscyamine sulfate[1][3].
Q: What is the primary use of ME-NAPHOS-MB-HYO 1 Tablets? A: They are used to treat symptoms of irritative voiding, including those associated with lower urinary tract infections and diagnostic procedures[1][3].
Q: Are there any precautions for using ME-NAPHOS-MB-HYO 1 Tablets during pregnancy or breastfeeding? A: Yes, the drug should be used with caution in pregnant women and breastfeeding mothers due to the potential for fetal harm and excretion in breast milk[1][3].
Q: How do the prices of ME-NAPHOS-MB-HYO 1 Tablets vary? A: Prices vary significantly depending on the pharmacy and location, with discounts and coupons available to reduce costs[4].
Q: What are the potential interactions with other medications when using ME-NAPHOS-MB-HYO 1 Tablets? A: The drug can interact with urinary alkalizers, thiazide diuretics, antimuscarinics, antacids/antidiarrheals, and other medications, which may affect its efficacy or increase side effects[1][3].
Cited Sources
- Drugs.com: ME/NaPhos/MB/Hyo 1 Tablets: Package Insert / Prescribing Info.
- Biomall: Methenamine Hippurate, 1g M226025-1g.
- DailyMed: ME NAPHOS MB HYO 1- urinary antiseptic antispasmodic tablet.
- WellRx: Me-Naphos-Mb-Hyo 1: Price, Uses, & Interactions.
- Method Pharmaceuticals: About Us.
More… ↓